TULPIŲ ŠEIMOS KLINIKA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 120,781 | 162,220 | 172,733 | 181,905 | 233,552 | 249,953 | 231,185 | 240,297 |
| Profit before tax | 38,208 | 74,612 | 95,371 | 52,830 | 85,633 | 78,633 | 39,928 | 52,395 |
| Net profit | 38,208 | 74,478 | 94,791 | 52,160 | 85,633 | 78,467 | 39,825 | 49,251 |
| Equity | 51,460 | 87,938 | 123,570 | 74,497 | 99,877 | 92,344 | 57,169 | 62,420 |
| Liabilities | -282 | 1,723 | 4,513 | 1,828 | 6,174 | 1,937 | 5,108 | 8,761 |
| Non-current assets | 842 | 296 | 296 | 114 | 114 | 114 | 114 | 114 |
| Current assets | 50,336 | 89,365 | 127,787 | 76,211 | 105,937 | 94,167 | 62,163 | 71,067 |
| Total assets | 51,178 | 89,661 | 128,083 | 76,325 | 106,051 | 94,281 | 62,277 | 71,181 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 46,613 | 41,779 | 38,474 |
| Social insurance contributions | - | - | - | - | - | 32,347 | 36,870 | 35,475 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +34.3% | +6.5% | +5.3% | +28.4% | +7.0% | -7.5% | +3.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 74.7% | 83.1% | 74.0% | 68.3% | 80.7% | 83.2% | 63.9% | 69.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 74.2% | 84.7% | 76.7% | 70.0% | 85.7% | 85.0% | 69.7% | 78.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 31.6% | 45.9% | 54.9% | 28.7% | 36.7% | 31.4% | 17.2% | 20.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 31.6% | 46.0% | 55.2% | 29.0% | 36.7% | 31.5% | 17.3% | 21.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,942 | 20,932 | 24,676 | 23,988 | 29,194 | 29,406 | 24,770 | 26,700 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
TULPIŲ ŠEIMOS KLINIKA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-04-24 | 2026-04-29 | 10.25 |
| 2026-01-16 | 2026-01-27 | 3033.63 |
| 2024-04-23 | 2024-05-05 | 1.72 |
| 2024-01-16 | 2024-01-16 | 2868.64 |
| 2023-06-16 | 2023-07-03 | 8.93 |
| 2023-05-16 | 2023-06-04 | 8.93 |
| 2023-05-02 | 2023-05-03 | 8.93 |
| 2023-04-27 | 2023-04-28 | 8.93 |
| 2023-04-25 | 2023-04-25 | 8.93 |
| 2023-01-17 | 2023-01-31 | 2125.63 |
TULPIŲ ŠEIMOS KLINIKA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-05 | 2025-04-05 | 210.15 |
| 2025-04-04 | 2025-04-04 | 2769.82 |
| 2025-01-09 | 2025-01-29 | 1.28 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
TULPIU ŠEIMOS KLINIKA, UAB (code 148321173) is a Private Limited Liability Company engaged in general medical practice activities. In 2025, the company generated revenue of €240.3K, up 3.9% year on year, and reported net profit of €49.3K, with a profit margin of 20.5%. Results improved from 2024, when revenue was €231.2K and net profit €39.8K, after a stronger 2023 performance of €250.0K revenue and €78.5K net profit. Over the 2023–2025 period, revenue declined from the 2023 peak, then partially recovered in 2025, while profitability fell sharply in 2024 before strengthening again. At the end of 2025, total assets were €71.2K, equity €62.4K and liabilities €8.8K, indicating a strongly equity-funded balance sheet with an equity ratio of 87.7% and debt-to-equity of 0.14. Asset turnover reached 3.38x. Profitability indicators remained high, with ROE at 78.9% and ROA at 69.2%. Revenue per employee was €26.7K and profit per employee €5.5K.